EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review

Sonia de Pedro Baena, Andrea Sariego Jamardo, Pedro Castro, Francisco Javier López González iD, Rocío Sánchez Carpintero iD, Alfredo Cerisola iD, Mónica Troncoso iD, Scarlet Witting, Andrés Barrios, Carmen Fons iD, Javier López Pisón, Juan Darío Ortigoza-Escobar iD

Movement Disorders Clinical Practice · 2023-11 · 10 (11) · 1671-1679

DOI: 10.1002/mdc3.13880 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 25.09.2023. Verfasst von Sonia de Pedro Baena und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rho‐related BTB domain‐containing protein 2 ( RHOBTB2 ) is a protein that interacts with cullin‐3, a crucial E3 ubiquitin ligase for mitotic cell division. RHOBTB2 has been linked to early infantile epileptic encephalopathy, autosomal dominant type 64 (OMIM618004), in 34 reported patients.

Methods

We present a case series of seven patients with RHOBTB2 ‐related disorders ( RHOBTB2 ‐RD), including a description of a novel heterozygous variant. We also reviewed previously published cases of RHOBTB2 ‐RD.

Results

The seven patients had ages ranging from 2 years and 8 months to 26 years, and all had experienced seizures before the age of one (onset, 4–12 months, median, 4 months), including various types of seizures. All patients in this cohort also had a movement disorder (onset, 0.3–14 years, median, 1.5 years). Six of seven had a baseline movement disorder, and one of seven only had paroxysmal dystonia. Stereotypies were noted in four of six, choreodystonia in three of six, and ataxia in one case with multiple movement phenotypes at baseline. Paroxysmal movement disorders were observed in six of seven patients for whom carbamazepine or oxcarbazepine treatment was effective in controlling acute or paroxysmal movement disorders. Four patients had acute encephalopathic episodes at ages 4 (one patient) and 6 (three patients), which improved following treatment with methylprednisolone. Magnetic resonance imaging scans revealed transient fluid‐attenuated inversion recovery abnormalities during these episodes, as well as myelination delay, thin corpus callosum, and brain atrophy. One patient had a novel RHOBTB2 variant (c.359G>A/p.Gly120Glu).

Conclusion

RHOBTB2 ‐RD is characterized by developmental delay or intellectual disability, early‐onset seizures, baseline movement disorders, acute or paroxysmal motor phenomena, acquired microcephaly, and episodes of acute encephalopathy. Early onsets of focal dystonia, acute encephalopathic episodes, episodes of tongue protrusion, or peripheral vasomotor disturbances are important diagnostic clues. Treatment with carbamazepine or oxcarbazepine was found to be effective in controlling acute or paroxysmal movement disorders. Our study highlights the clinical features and treatment response of RHOBTB2 ‐RD.

Schlagwörter

Stichwörter der Autor:innen

RHOBTB2acute encephalopathyepileptic encephalopathykinesigenic paroxysmal dyskinesiamovement disordersoxcarbazepine

Autor:innen und Institutionen

  • Pediatric Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Pediatric Neurology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Department of Pediatric Neurology, Hospital Gregorio Marañón, Madrid, Spain.
  • Neurology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.
  • Paediatric Neurology Unit. Paediatric Department, University Clinic of Navarra, Pamplona, Spain.
  • Pediatric Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

ORCID-Profile: Francisco Javier López González, Rocío Sánchez Carpintero, Alfredo Cerisola, Mónica Troncoso, Carmen Fons, Juan Darío Ortigoza-Escobar

Zitieren

APA

de Pedro Baena, S., Sariego Jamardo, A., Castro, P., López González, F. J., Sánchez Carpintero, R., Cerisola, A., Troncoso, M., Witting, S., Barrios, A., Fons, C., López Pisón, J., & Ortigoza-Escobar, J. D. (2023). Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review. Movement Disorders Clinical Practice, 10(11), 1671-1679. https://doi.org/10.1002/mdc3.13880

Vancouver

de Pedro Baena S, Sariego Jamardo A, Castro P, López González FJ, Sánchez Carpintero R, Cerisola A, et al. Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review. Movement Disorders Clinical Practice. 2023;10(11):1671-1679. doi:10.1002/mdc3.13880

BibTeX
@article{dePedroBaena2023,
  author = {de Pedro Baena, Sonia and Sariego Jamardo, Andrea and Castro, Pedro and López González, Francisco Javier and Sánchez Carpintero, Rocío and Cerisola, Alfredo and Troncoso, Mónica and Witting, Scarlet and Barrios, Andrés and Fons, Carmen and López Pisón, Javier and Ortigoza-Escobar, Juan Darío},
  title = {Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review},
  journal = {Movement Disorders Clinical Practice},
  year = {2023},
  volume = {10},
  number = {11},
  pages = {1671--1679},
  doi = {10.1002/mdc3.13880}
}
Kostenlos starten →